Chronic Effects of Natural and Interesterified Fats Margarine on Insulin Sensitivity and Selected Markers of Cardiovascular Diseases (CVD)
NCT ID: NCT02192047
Last Updated: 2014-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2012-09-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Effects of Natural and Interesterified Fats-margarine on Lipemic and Insulinemic Response
NCT02194673
The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids
NCT02922062
Multicountry Studies on the Effect of Positional Distribution of Fatty Acids at Triglyceride Backbone on Serum Lipids, Lipoprotein(a) and LDL-subclasses in Healthy Malaysian Volunteers
NCT02802904
Effects of Dietary Fats on Cardiovascular Health and Insulin Sensitivity in Subjects With Abdominal Obesity
NCT01665482
The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety
NCT02365987
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
palm olein margarine
8 weeks
Palm Olein
8 weeks
IE palm olein margarine
8 weeks
IE Palm olein
8 weeks
IE soybean oil-based margarine
8 weeks
IE soybean oil-based
8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Palm Olein
8 weeks
IE Palm olein
8 weeks
IE soybean oil-based
8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Staff and students of International Medical University, IMU/ Staff of Malaysian Palm Oil Board, MPOB to facilitate centralized consumption of the test fats/snacks
* BMI 21 - 30 kg/m2
Exclusion Criteria
* History of type 2 diabetes mellitus, cancer, stomach ulcers, drug abuse or alcoholism
* Smokers
* On lipid/blood pressure- lowering medication/supplements
* Blood pressure\>140/90 mmHg
* Fasting total cholesterol \> 6.5 mmol/L
* Fasting TAG \> 2.0 mmol/L
* Candidates who are going abroad during the planned schedule for the dietary intervention
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IMU University, Malaysia
OTHER
Universiti Putra Malaysia
OTHER
Malaysia Palm Oil Board
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Voon Phooi Tee, Ph.D
Role: PRINCIPAL_INVESTIGATOR
MPOB
Ng Yen Teng, BSc
Role: PRINCIPAL_INVESTIGATOR
IMU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Putra Malaysia
Serdang, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PD 174/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.